GeneCraft Inc.
PrivateLast Round
Series A
Jan 15, 2024
Total Funding Raised
$7.48M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
GeneCraft Inc. is a biotechnology company that develops gene therapies for the treatment of cancer, specifically focusing on K-RAS mutated lung cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneCraft Inc. Comparables
Compare GeneCraft Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trogenix | 75% | |
| Vironexis Biotherapeutics | 73% | |
| Siren Biotechnology | 71% |
GeneCraft Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 15, 2024 |
GeneCraft Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Infobank Corp | Series A |
| Seoul National University Technology Holdings | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 123% MoM, reaching 1.2K.
- Aug 22, 2026
Monthly visitors grew 102% MoM.
GeneCraft Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GeneCraft Inc.'s valuation, stock price, and market status.
Is GeneCraft Inc. a public or private company?
GeneCraft Inc. is a private company.
What is the current stock price of GeneCraft Inc.?
GeneCraft Inc. is a private company, so its shares have no public market price. Caplight tracks GeneCraft Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GeneCraft Inc. worth (valuation)?
Valuation information for GeneCraft Inc. is not publicly available.
Can I buy GeneCraft Inc. stock?
GeneCraft Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GeneCraft Inc.'s last funding round?
GeneCraft Inc.'s most recent funding round was Series A on January 15, 2024.
Who are the main investors in GeneCraft Inc.?
Key investors in GeneCraft Inc. include Infobank Corp, Seoul National University Technology Holdings.
Will GeneCraft Inc. IPO soon?
No public IPO plans have been announced for GeneCraft Inc..
How can I track GeneCraft Inc. secondary market activity?
Caplight tracks bids, offers, and trades in GeneCraft Inc.'s shares on secondary markets.